BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 24374535)

  • 1. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy.
    Nandivada P; Chang MI; Potemkin AK; Carlson SJ; Cowan E; Oʼloughlin AA; Mitchell PD; Gura KM; Puder M
    Ann Surg; 2015 Jan; 261(1):172-9. PubMed ID: 24374535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.
    Nandivada P; Baker MA; Mitchell PD; O'Loughlin AA; Potemkin AK; Anez-Bustillos L; Carlson SJ; Dao DT; Fell GL; Gura KM; Puder M
    Am J Clin Nutr; 2016 Sep; 104(3):663-70. PubMed ID: 27510535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.
    Puder M; Valim C; Meisel JA; Le HD; de Meijer VE; Robinson EM; Zhou J; Duggan C; Gura KM
    Ann Surg; 2009 Sep; 250(3):395-402. PubMed ID: 19661785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
    Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in Parenteral Nutrition-Associated Cholestasis With the Use of Omegaven in an Infant With Short Bowel Syndrome.
    Strang BJ; Reddix BA; Wolk RA
    Nutr Clin Pract; 2016 Oct; 31(5):647-53. PubMed ID: 27143651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
    Rollins MD; Scaife ER; Jackson WD; Meyers RL; Mulroy CW; Book LS
    Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.
    Calkins KL; Dunn JC; Shew SB; Reyen L; Farmer DG; Devaskar SU; Venick RS
    JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):682-92. PubMed ID: 23894176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric parenteral nutrition-associated liver disease and cholestasis: Novel advances in pathomechanisms-based prevention and treatment.
    Orso G; Mandato C; Veropalumbo C; Cecchi N; Garzi A; Vajro P
    Dig Liver Dis; 2016 Mar; 48(3):215-22. PubMed ID: 26698410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parenteral fish oil and liver function tests in hospitalized adult patients receiving parenteral nutrition: A propensity score-matched analysis.
    Llop-Talaveron JM; Badia-Tahull MB; Leiva-Badosa E; Ramon-Torrel JM
    Clin Nutr; 2017 Aug; 36(4):1082-1088. PubMed ID: 27435303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of biochemical liver function with low-dose soy-based lipids in children with intestinal failure-associated liver disease.
    Khan FA; Fisher JG; Sparks EA; Potemkin A; Duggan C; Raphael BP; Modi BP; Jaksic T
    J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):375-7. PubMed ID: 25714580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of hepatic fibrosis in pediatric intestinal failure patients treated with intravenous fish oil lipid emulsion.
    Belza C; Thompson R; Somers GR; de Silva N; Fitzgerald K; Steinberg K; Courtney-Martin G; Wales PW; Avitzur Y
    J Pediatr Surg; 2017 May; 52(5):795-801. PubMed ID: 28189450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Favorable Outcomes of Preterm Infants With Parenteral Nutrition-associated Liver Disease Treated With Intravenous Fish Oil-based Lipid Emulsion.
    Sorrell M; Moreira A; Green K; Jacob R; Tragus R; Keller L; Quinn A; McCurnin D; Gong A; El Sakka A; Mittal N; Blanco C
    J Pediatr Gastroenterol Nutr; 2017 May; 64(5):783-788. PubMed ID: 28437326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind randomised controlled trial of fish oil-based versus soy-based lipid preparations in the treatment of infants with parenteral nutrition-associated cholestasis.
    Lam HS; Tam YH; Poon TC; Cheung HM; Yu X; Chan BP; Lee KH; Lee BS; Ng PC
    Neonatology; 2014; 105(4):290-6. PubMed ID: 24576844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy.
    Premkumar MH; Carter BA; Hawthorne KM; King K; Abrams SA
    J Pediatr; 2013 Apr; 162(4):793-798.e1. PubMed ID: 23164314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fish oil-based lipid emulsion in the treatment of parenteral nutrition-associated liver disease.
    Cowan E; Nandivada P; Puder M
    Curr Opin Pediatr; 2013 Apr; 25(2):193-200. PubMed ID: 23407182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Disease in Patients on Total Parenteral Nutrition.
    Mitra A; Ahn J
    Clin Liver Dis; 2017 Nov; 21(4):687-695. PubMed ID: 28987256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and treatment of parenteral nutrition-associated liver disease.
    Xu ZW; Li YS
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):586-93. PubMed ID: 23232629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon-Like Peptide 2 Improves Cholestasis in Parenteral Nutrition--Associated Liver Disease.
    Lim DW; Wales PW; Josephson JK; Nation PN; Wizzard PR; Sergi CM; Field CJ; Sigalet DL; Turner JM
    JPEN J Parenter Enteral Nutr; 2016 Jan; 40(1):14-21. PubMed ID: 25280755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs.
    Ng K; Stoll B; Chacko S; Saenz de Pipaon M; Lauridsen C; Gray M; Squires EJ; Marini J; Zamora IJ; Olutoye OO; Burrin DG
    JPEN J Parenter Enteral Nutr; 2016 Jul; 40(5):656-71. PubMed ID: 25596209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enteral fish oil for treatment of parenteral nutrition-associated liver disease in six infants with short-bowel syndrome.
    Tillman EM; Crill CM; Black DD; Hak EB; Lazar LF; Christensen ML; Huang EY; Helms RA
    Pharmacotherapy; 2011 May; 31(5):503-9. PubMed ID: 21923431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.